Diverging HFpEF Phenotypes : patient-tailoreD targeting of anti-Inflammatory pathways to limit Ventricular and Atrial remodelling

Funder: AGENCIA ESTATAL DE INVESTIGACION

Duration: from 30 May 2024 to 29 May 2027 (36 months) Current

198,750.00 EUR

Of European scope.

Call: ERA4HEALTHCVD CARDINNOV 23: ¿Research targeting development of innovative therapeutic strategies in cardiovascular disease¿ (AGENCIA ESTATAL DE INVESTIGACION)

Researchers

Arantxa González Miqueo

Leader

Diverging HFpEF Phenotypes : patient-tailoreD targeting of anti-Inflammatory pathways to limit Ventricular and Atrial remodelling

Researchers Filter by first and last name Filter $(document).ready(function () { new FilterComponent("miembros/filtrar", "personas", "#miembros", ".proyecto-miembros__item").init(); });

Researchers